RenovoRx Inc <RNXT.OQ> expected to post a loss of 8 cents a share - Earnings Preview
RenovoRx Inc RNXT.OQ RNXT.O is expected to show a rise in quarterly revenue when it reports results on August 14 for the period ending June 30 2025
The Mountain View California-based company is expected to report revenue of $329.67 thousand, according to the mean estimate from 3 analysts, based on LSEG data.
LSEG's mean analyst estimate for RenovoRx Inc is for a loss of 8 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for RenovoRx Inc is $3.75, about 70.3% above its last closing price of $1.12
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2025 | -0.08 | -0.08 | -0.08 | Met | 0 |
Dec. 31 2025 | -0.12 | -0.11 | -0.13 | Missed | -18.2 |
Sep. 30 2024 | -0.12 | -0.12 | -0.10 | Beat | 16.7 |
Jun. 30 2024 | -0.10 | -0.10 | -0.10 | Met | 0 |
Mar. 31 2024 | -0.13 | -0.14 | -0.07 | Beat | 51.7 |
Dec. 31 2023 | -0.30 | -0.30 | -0.31 | Missed | -2.2 |
Sep. 30 2023 | -0.30 | -0.30 | -0.13 | Beat | 56.7 |
Jun. 30 2023 | -0.25 | -0.25 | -0.31 | Missed | -24 |
This summary was machine generated August 12 at 21:00 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Related Articles
The Market Game of the Quantitative King: How Renaissance Technologies Locks in Excess Returns Amid the 2025 Turmoil
TradingKey - Founded by mathematician James Simons, Renaissance Technologies LLC is a global leader in quantitative investing, renowned for its data-driven, innovative approach. The firm eschews traditional fundamental analysis, relying instead on advanced mathematical models
Bridgewater Associates Q2 2025 13F Analysis: Founder Ray Dalio’s Final Act
TradingKey - Bridgewater Associates, the world’s largest hedge fund and renowned for its macroeconomic analysis, continues to command market respect with its “risk parity” strategy and precise economic cycle timing..jpg)
U.S. July CPI Commentary: Obstacles Cleared, Where Will U.S. Stocks Go Next?
TradingKey - On 12 August 2025, the United States released its Consumer Price Index (CPI) data for July. In terms of headline inflation, the CPI rose by 2.7% year-on-year in the month, slightly lower than the expected 2.8%. However, core CPI climbed 3.1% year-on-year, edging past the projected 3.0%.
Which Crypto Companies Are Filing for IPOs — and Who Might Be the Next Circle?
Circle’s IPO has opened the floodgates for crypto firms to tap public markets. From Gemini and Bullish to Kraken and ConsenSys, the next wave of listings is already forming.
[IN-DEPTH ANALYSIS] UnitedHealth (UNH): Can the Healthcare Giant Recover After Its Epic Collapse?
Once a Wall Street sweetheart, UnitedHealth Group (UNH) dominated the US healthcare industry with its unbeatable vertical empire, spanning insurance, clinics, pharmacies, and data analytics..jpg)
